BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 31851103)

  • 1. Serum Levels of Insulin-like Growth Factor 1 and Insulin-like Growth Factor-binding Protein 2 as a Novel Biomarker in the Detection of Pancreatic Adenocarcinoma.
    Wlodarczyk B; Borkowska A; Wlodarczyk P; Malecka-Panas E; Gasiorowska A
    J Clin Gastroenterol; 2020 Oct; 54(9):e83-e88. PubMed ID: 31851103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor 1 and insulin-like growth factor binding protein 2 serum levels as potential biomarkers in differential diagnosis between chronic pancreatitis and pancreatic adenocarcinoma in reference to pancreatic diabetes.
    Włodarczyk B; Borkowska A; Włodarczyk P; Małecka-Panas E; Gąsiorowska A
    Prz Gastroenterol; 2021; 16(1):36-42. PubMed ID: 33986886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CA 19-9 but Not IGF-1/IGFBP-2 Is a Useful Biomarker for Pancreatic Ductal Adenocarcinoma (PDAC) and Chronic Pancreatitis (CP) Differentiation.
    Wlodarczyk B; Durko L; Wlodarczyk P; Talar-Wojnarowska R; Malecka-Wojciesko E
    J Clin Med; 2023 Jun; 12(12):. PubMed ID: 37373743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of insulin-like growth factor (IGF-1) and retinol binding protein (RBP-4) levels in patients with newly diagnosed pancreatic adenocarcinoma (PDAC).
    Wlodarczyk B; Gasiorowska A; Borkowska A; Malecka-Panas E
    Pancreatology; 2017; 17(4):623-628. PubMed ID: 28499807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factors and insulin-like growth factor binding proteins in adult patients with severe liver disease before and after orthotopic liver transplantation.
    Weber MM; Auernhammer CJ; Lee PD; Engelhardt D; Zachoval R
    Horm Res; 2002; 57(3-4):105-12. PubMed ID: 12006706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum IGF-I, IGF-II, IGFBP-3, and IGF-I/IGFBP-3 molar ratio and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.
    Douglas JB; Silverman DT; Pollak MN; Tao Y; Soliman AS; Stolzenberg-Solomon RZ
    Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2298-306. PubMed ID: 20699371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.
    Jehle PM; Ostertag A; Schulten K; Schulz W; Jehle DR; Stracke S; Fiedler R; Deuber HJ; Keller F; Boehm BO; Baylink DJ; Mohan S
    Kidney Int; 2000 Feb; 57(2):423-36. PubMed ID: 10652019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a novel assay for IGFBP-2 complexed with IGF-I and-II in human serum.
    Agerholm J; Hjortebjerg R; Espelund U; Rasmussen TR; Folkersen B; Bjerre M; Frystyk J
    Growth Horm IGF Res; 2020 Apr; 51():38-45. PubMed ID: 32035328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral contraceptives increase insulin-like growth factor binding protein-1 concentration in women with polycystic ovarian disease.
    Suikkari AM; Tiitinen A; Stenman UH; Seppälä M; Laatikainen T
    Fertil Steril; 1991 May; 55(5):895-9. PubMed ID: 1708731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum insulin-like growth factor type 1, insulin-like growth factor-binding protein-1, and insulin-like growth factor-binding protein-3 concentrations in patients with thyroid dysfunction.
    Iglesias P; Bayón C; Méndez J; Gancedo PG; Grande C; Diez JJ
    Thyroid; 2001 Nov; 11(11):1043-8. PubMed ID: 11762714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between carbohydrate metabolism and serum insulin-like growth factor system in postmenopausal women: comparison of endometrial cancer patients with healthy controls.
    Rutanen EM; Stenman S; Blum W; Kärkkäinen T; Lehtovirta P; Stenman UH
    J Clin Endocrinol Metab; 1993 Jul; 77(1):199-204. PubMed ID: 7686914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of insulin-like growth factor-binding protein-2 (IGFBP-2), IGFBP-3, and IGF-I for assessing growth hormone status in short children.
    Smith WJ; Nam TJ; Underwood LE; Busby WH; Celnicker A; Clemmons DR
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1294-9. PubMed ID: 7521346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor-I (IGF-I) and IGF-binding proteins in children with nephrotic syndrome.
    Lee DY; Park SK; Kim JS
    J Clin Endocrinol Metab; 1996 May; 81(5):1856-60. PubMed ID: 8626847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 17beta-estradiol regulation of human growth hormone (hGH), insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding protein-3 (IGFBP-3) axis in hypoestrogenic, hypergonadotropic women.
    Milewicz T; Krzysiek J; Sztefko K; Radowicki S; Krzyczkowska-Sendrakowska M
    Endokrynol Pol; 2005; 56(6):876-82. PubMed ID: 16821205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased bioavailability of insulin-like growth factor-I, a cause of catabolism in hemodialysis patients?
    Lindgren BF; Odar-Cederlöf I; Ericsson F; Brismar K
    Growth Regul; 1996 Sep; 6(3):137-43. PubMed ID: 8894646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor-I (IGF-I), insulin-like growth factor binding proteins (IGFBP) and insulin-like growth factor type I receptor in children with various status of chronic renal failure.
    Houang M; Cabrol S; Perin L; Ducos B; Bensman A; Le Bouc Y
    Growth Horm IGF Res; 2000 Dec; 10(6):332-41. PubMed ID: 11161964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study.
    Stattin P; Bylund A; Rinaldi S; Biessy C; Déchaud H; Stenman UH; Egevad L; Riboli E; Hallmans G; Kaaks R
    J Natl Cancer Inst; 2000 Dec; 92(23):1910-7. PubMed ID: 11106682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The maternal insulin-like growth factor (IGF) and IGF-binding protein response to trisomic pregnancy during the first trimester: a possible diagnostic tool for trisomy 18 pregnancies.
    Miell JP; Langford KS; Jones JS; Noble P; Westwood M; White A; Nicolaides KH
    J Clin Endocrinol Metab; 1997 Jan; 82(1):287-92. PubMed ID: 8989275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum insulin-like growth factor-I, insulin-like growth factor binding proteins, and bone mineral content in hyperthyroidism.
    Lakatos P; Foldes J; Nagy Z; Takacs I; Speer G; Horvath C; Mohan S; Baylink DJ; Stern PH
    Thyroid; 2000 May; 10(5):417-23. PubMed ID: 10884189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian expression of insulin-like growth factor-I (IGF-I), IGF binding proteins, and growth hormone (GH) receptor in heifers actively immunized against GH-releasing factors.
    Cohick WS; Armstrong JD; Whitacre MD; Lucy MC; Harvey RW; Campbell RM
    Endocrinology; 1996 May; 137(5):1670-7. PubMed ID: 8612500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.